𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia

✍ Scribed by Yupo Ma; Adnan Mansour; B. Nebiyou Bekele; Xian Zhou; Michael J. Keating; Susan O'Brien; Francis J. Giles; Maher Albitar


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
253 KB
Volume
100
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Patients with chronic lymphocytic leukemia (CLL) that transforms to Richter syndrome (RS) frequently show atypical lymphocytes in bone marrow; however, a diagnosis of RS requires confirmation of the presence of sheets of large cells in bone marrow or lymph nodes.

METHODS

In this study, the authors evaluated the clinical significance of scattered large cells in bone marrow. They assessed the possibility of predicting transformation to RS in bone marrow smears by counting the percentages of prolymphocytes and large cells in 78 patients with CLL and 29 patients with lymph node biopsy‐confirmed RS.

RESULTS

The percentage of large cells was found to be correlated with decreasing survival in a continuous fashion (P = 0.006). It is interesting to note that patients who had > 7% large cells in the bone marrow and elevated Ξ²~2~‐microglobulin (Ξ²~2~‐M) levels (> 5 mg/L) had a survival duration identical to that of patients with RS, and these factors together were a strong predictor of RS (P < 0.001).

CONCLUSIONS

Patients with CLL who had bone marrow that contained > 7% large cells and who had Ξ²~2~‐M levels > 5 mg/L had a disease that was similar to RS, and the combination of large cells and Ξ²~2~‐M can be used as a surrogate marker for RS. Cancer 2004. Β© 2004 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


The significance of the bone marrow biop
✍ Zengin, Nurullah; Kars, Ay?e; Sungur, Arzu; Zengin, Neslihan ?nci; Hayran, Mutlu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 45 KB πŸ‘ 3 views

Although bone marrow biopsy pattern (BMBP) has long been suggested to be an independent prognostic factor in chronic lymphocytic leukemia (CLL), conflicting reports continue to appear in the literature. To investigate this issue we retrospectively reviewed 70 CLL patients who had undergone bone marr

The clinical course of lung carcinoma in
✍ Kalpaj Parekh; Valerie Rusch; Mark Kris πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e

Enzymatic activity of circulating protea
✍ Wanlong Ma; Hagop Kantarjian; Susan O'Brien; Iman Jilani; Xi Zhang; Zeev Estrov; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

## Abstract ## BACKGROUND The ubiquitin‐proteasome pathway has been implicated in the pathogenesis of many hematologic malignancies. ## METHODS The authors measured proteasome peptidase activity levels in plasma samples from 225 patients with chronic lymphocytic leukemia (CLL) and correlated the